Cyberonics Stock Price, News & Analysis (NASDAQ:CYBX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Cyberonics (NASDAQ:CYBX)

Cyberonics logoCyberonics, Inc. is a medical device company. The Company is engaged in the design, development, sale and marketing of medical devices for epilepsy, depression and heart failure. Its seminal product, the VNS Therapy System, is an implantable device that provides neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment-resistant depression (TRD). The Company's VITARIA System is an implantable device that provides a form of neuromodulation therapy for the treatment of chronic heart failure (CHF). The VNS Therapy System and its VITARIA System include an implantable pulse generator to stimulate the vagus nerve; a lead that conducts current pulses from the pulse generator to the vagus nerve; a surgical instrument to assist with the implant procedure; equipment to enable the treating physician to set the pulse generator stimulation parameters for the patient; instruction manuals, and in the VNS Therapy System, magnets to suspend or induce stimulation manually.

Receive CYBX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYBX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:CYBX
CUSIP23251P10
Phone+1-281-2287200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$2.14
Net IncomeN/A
Net Margins15.33%
Return on Equity17.49%
Return on Assets15.23%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Cyberonics (NASDAQ:CYBX) Frequently Asked Questions

What is Cyberonics' stock symbol?

Cyberonics trades on the NASDAQ under the ticker symbol "CYBX."

Who are some of Cyberonics' key competitors?

How do I buy Cyberonics stock?

Shares of Cyberonics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Cyberonics?

Cyberonics' mailing address is 100 Cyberonics Blvd, HOUSTON, TX 77058-2069, United States. The medical device company can be reached via phone at +1-281-2287200.


MarketBeat Community Rating for Cyberonics (CYBX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  263
MarketBeat's community ratings are surveys of what our community members think about Cyberonics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cyberonics (NASDAQ:CYBX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Cyberonics (NASDAQ:CYBX) Earnings History and Estimates Chart

Earnings by Quarter for Cyberonics (NASDAQ:CYBX)

Cyberonics (NASDAQ CYBX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/20/2015Q116$0.62$0.72$76.78 million$81.00 millionViewListenView Earnings Details
6/4/2015Q415$0.63$0.64$77.44 million$74.10 millionViewListenView Earnings Details
2/26/2015Q315$0.57$0.59$72.02 million$72.10 millionViewN/AView Earnings Details
11/20/2014Q215$0.58$0.63$75.70 million$73.40 millionViewN/AView Earnings Details
8/21/2014Q115$0.55$0.53$74.10 million$72.00 millionViewN/AView Earnings Details
6/4/2014Q414$0.54$0.55$76.70 million$74.80 millionViewN/AView Earnings Details
2/20/2014Q314$0.49$0.51$69.65 million$68.20 millionViewN/AView Earnings Details
11/21/2013Q2$0.48$0.50$69.54 million$70.10 millionViewListenView Earnings Details
8/22/2013Q1 2014$0.46$0.48$67.80 million$67.40 millionViewN/AView Earnings Details
6/5/2013Q4 2013$0.42$0.46$63.98 million$68.30 millionViewN/AView Earnings Details
2/22/2013Q3 2013$0.38$0.47$60.59 million$62.70 millionViewN/AView Earnings Details
11/16/2012Q312$0.39$0.44$59.80 million$63.00 millionViewN/AView Earnings Details
8/28/2012Q113$0.36$0.38$58.45 million$60.30 millionViewN/AView Earnings Details
6/6/2012$0.35$0.38ViewN/AView Earnings Details
2/24/2012$0.30$0.34ViewN/AView Earnings Details
11/18/2011$0.30$0.32ViewN/AView Earnings Details
8/25/2011$0.26$0.28ViewN/AView Earnings Details
6/2/2011$0.29$0.26ViewN/AView Earnings Details
3/2/2011$0.24$0.25ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cyberonics (NASDAQ:CYBX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cyberonics (NASDAQ:CYBX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cyberonics (NASDAQ CYBX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Cyberonics (NASDAQ:CYBX)

Cyberonics (NASDAQ CYBX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2015Daniel Jeffrey MooreCEOSell2,500$68.65$171,625.0088,317View SEC Filing  
10/1/2015Gregory H BrowneCFOSell2,000$60.20$120,400.0034,003View SEC Filing  
9/30/2015Jon T TremmelDirectorSell2,000$60.29$120,580.007,075View SEC Filing  
9/8/2015Joseph E LaptewiczDirectorSell3,687$66.95$246,844.6517,196View SEC Filing  
9/1/2015Gregory H BrowneCFOSell2,000$63.88$127,760.0036,003View SEC Filing  
8/31/2015Hugh M MorrisonDirectorSell1,500$65.41$98,115.008,815View SEC Filing  
8/27/2015Jon T. TremmelDirectorSell5,050$66.27$334,663.509,075View SEC Filing  
8/24/2015Darren AlchVPSell1,000$62.18$62,180.0010,853View SEC Filing  
8/17/2015Daniel Jeffrey MooreCEOSell2,500$59.05$147,625.00View SEC Filing  
7/15/2015Daniel Jeffrey MooreCEOSell2,500$60.90$152,250.00View SEC Filing  
7/1/2015Gregory H BrowneCFOSell2,000$61.11$122,220.00View SEC Filing  
6/15/2015Daniel Jeffrey MooreCEOSell2,500$61.34$153,350.00View SEC Filing  
6/8/2015Jon T TremmelDirectorSell4,307$62.09$267,421.63View SEC Filing  
6/1/2015Gregory H BrowneCFOSell2,000$65.31$130,620.00View SEC Filing  
4/15/2015Daniel Jeffrey MooreCEOSell2,500$65.39$163,475.00View SEC Filing  
4/1/2015Gregory H BrowneCFOSell2,000$64.63$129,260.00View SEC Filing  
3/16/2015Daniel Jeffrey MooreCEOSell2,500$66.76$166,900.00View SEC Filing  
3/2/2015David S WiseSVPSell2,000$69.02$138,040.00View SEC Filing  
2/17/2015Daniel Jeffrey MooreCEOSell2,500$56.54$141,350.00View SEC Filing  
2/5/2015Daniel Jeffrey MooreCEOSell1,500$56.64$84,960.00View SEC Filing  
2/2/2015David S WiseSVPSell2,000$55.12$110,240.00View SEC Filing  
1/15/2015Daniel Jeffrey MooreCEOSell2,500$55.67$139,175.00View SEC Filing  
1/5/2015Daniel Jeffrey MooreCEOSell1,500$54.12$81,180.00View SEC Filing  
1/2/2015David S WiseSVPSell2,000$54.67$109,340.00View SEC Filing  
12/1/2014David S WiseSVPSell2,000$53.65$107,300.00View SEC Filing  
11/24/2014Darren AlchVPSell2,422$54.47$131,926.34View SEC Filing  
11/24/2014Hugh M MorrisonDirectorSell2,454$53.79$132,000.66View SEC Filing  
11/24/2014Milton Mayo MorrisSVPSell7,547$54.18$408,896.46View SEC Filing  
11/3/2014David S WiseSVPSell2,000$52.19$104,380.00View SEC Filing  
10/1/2014David S WiseSVPSell2,000$50.09$100,180.00View SEC Filing  
9/15/2014Daniel Jeffrey MooreCEOSell7,000$54.32$380,240.00View SEC Filing  
9/11/2014Darren AlchVPSell1,000$53.72$53,720.00View SEC Filing  
9/10/2014Hugh M MorrisonDirectorSell500$54.13$27,065.00View SEC Filing  
9/5/2014Daniel Jeffrey MooreCEOSell4,750$55.30$262,675.00View SEC Filing  
9/2/2014David S WiseSVPSell2,000$56.33$112,660.00View SEC Filing  
8/29/2014Milton Mayo MorrisSVPSell13,000$57.15$742,950.00View SEC Filing  
8/15/2014Daniel Jeffrey MooreCEOSell7,000$60.74$425,180.00View SEC Filing  
8/5/2014Daniel Jeffrey MooreCEOSell4,750$60.56$287,660.00View SEC Filing  
7/15/2014Daniel Jeffrey MooreCEOSell7,000$59.36$415,520.00View SEC Filing  
7/7/2014Daniel Jeffrey MooreCEOSell4,750$61.73$293,217.50View SEC Filing  
6/20/2014Milton Mayo MorrisSVPSell9,224$58.06$535,545.44View SEC Filing  
6/16/2014Daniel Jeffrey MooreCEOSell7,000$57.18$400,260.00View SEC Filing  
6/11/2014Bryan D OlinVPSell10,000$58.17$581,700.00View SEC Filing  
6/5/2014Daniel Jeffrey MooreCEOSell4,750$57.20$271,700.00View SEC Filing  
5/16/2014Gregory BrowneCFOSell1,500$59.23$88,845.0061,942View SEC Filing  
5/5/2014Daniel Jeffrey MooreCEOSell4,750$62.08$294,880.00158,163View SEC Filing  
5/5/2014David WiseSVPSell2,000$62.09$124,180.0073,055View SEC Filing  
4/16/2014Gregory BrowneCFOSell1,500$61.61$92,415.0063,442View SEC Filing  
4/15/2014Daniel Jeffrey MooreCEOSell7,000$61.22$428,540.00158,163View SEC Filing  
4/7/2014Daniel Jeffrey MooreCEOSell4,750$61.81$293,597.50161,163View SEC Filing  
4/1/2014David WiseSVPSell2,000$65.56$131,120.0075,055View SEC Filing  
3/17/2014Daniel Jeffrey MooreCEOSell7,000$66.62$466,340.00161,163View SEC Filing  
3/17/2014Gregory BrowneCFOSell1,500$66.60$99,900.0064,942View SEC Filing  
3/5/2014Daniel Jeffrey MooreCEOSell4,750$69.59$330,552.50170,783View SEC Filing  
3/3/2014David WiseSVPSell2,000$67.58$135,160.0077,055View SEC Filing  
2/28/2014Guy JacksonDirectorSell8,000$69.08$552,640.0034,288View SEC Filing  
2/27/2014Alfred NovakDirectorSell1,274$67.96$86,581.0414,705View SEC Filing  
2/26/2014Bryan OlinVPSell10,672$68.34$729,324.4863,424View SEC Filing  
2/24/2014Darren AlchVPSell1,750$69.19$121,082.5018,874View SEC Filing  
2/6/2014Randal SimpsonVPSell3,000$66.17$198,510.0042,285View SEC Filing  
2/5/2014Daniel Jeffrey MooreCEOSell4,750$66.36$315,210.00173,783View SEC Filing  
2/3/2014David WiseSVPSell2,000$65.57$131,140.0079,055View SEC Filing  
1/16/2014Gregory BrowneCFOSell1,500$69.32$103,980.0067,942View SEC Filing  
1/15/2014Daniel Jeffrey MooreCEOSell7,000$68.81$481,670.00173,783View SEC Filing  
1/6/2014Daniel Jeffrey MooreCEOSell4,750$64.72$307,420.00176,783View SEC Filing  
1/6/2014Randal SimpsonVPSell3,000$64.89$194,670.0045,285View SEC Filing  
12/10/2013Hugh MorrisonDirectorSell1,000$66.54$66,540.0011,454View SEC Filing  
12/9/2013Alfred NovakDirectorSell2,750$67.49$185,597.5019,600View SEC Filing  
12/9/2013Gregory BrowneCFOSell10,000$68.01$680,100.0070,942View SEC Filing  
12/5/2013Daniel Jeffrey MooreCEOSell4,750$69.48$330,030.00179,783View SEC Filing  
12/3/2013Mark VerrattiVPSell18,750$71.12$1,333,500.0052,719View SEC Filing  
12/2/2013David WiseSVPSell2,000$69.62$139,240.0083,055View SEC Filing  
12/2/2013Randal SimpsonVPSell5,000$69.23$346,150.0048,285View SEC Filing  
11/1/2013David S WiseSVPSell2,000$56.83$113,660.00View SEC Filing  
11/1/2013Randal L SimpsonVPSell5,000$56.87$284,350.00View SEC Filing  
10/16/2013Gregory H BrowneCFOSell1,500$54.09$81,135.00View SEC Filing  
10/15/2013Daniel Jeffrey MooreCEOSell7,000$53.07$371,490.00View SEC Filing  
10/7/2013Daniel Jeffrey MooreCEOSell4,750$50.96$242,060.00185,783View SEC Filing  
10/3/2013Randal SimpsonVPSell5,000$50.84$254,200.0048,285View SEC Filing  
9/16/2013Daniel Jeffrey MooreCEOSell7,000$51.74$362,180.00185,783View SEC Filing  
9/16/2013Gregory BrowneCFOSell1,500$51.71$77,565.0083,942View SEC Filing  
9/5/2013Daniel Jeffrey MooreCEOSell3,000$51.89$155,670.00View SEC Filing  
9/3/2013David WiseSVPSell2,000$51.02$102,040.0089,055View SEC Filing  
8/26/2013David WiseSVPSell21,273$55.02$1,170,440.4691,055View SEC Filing  
8/26/2013Gregory BrowneCFOSell9,413$55.57$523,080.4185,442View SEC Filing  
8/21/2013Sherrie PerkinsVPSell3,000$55.00$165,000.0024,161View SEC Filing  
8/16/2013Gregory BrowneCFOSell1,500$52.66$78,990.0094,855View SEC Filing  
8/5/2013Daniel Jeffrey MooreCEOSell3,000$52.63$157,890.00191,883View SEC Filing  
8/1/2013David WiseSVPSell2,000$50.88$101,760.0091,055View SEC Filing  
7/16/2013Gregory H BrowneCFOSell1,500$53.43$80,145.00View SEC Filing  
7/15/2013Daniel Jeffrey MooreCEOSell7,000$53.10$371,700.00View SEC Filing  
7/10/2013Sherrie L PerkinsVPSell1,415$53.00$74,995.00View SEC Filing  
7/5/2013Daniel Jeffrey MooreCEOSell3,000$52.28$156,840.00View SEC Filing  
7/1/2013Milton Mayo MorrisSVPSell5,000$52.03$260,150.00View SEC Filing  
6/27/2013Milton Mayo MorrisSVPSell4,608$51.69$238,187.52View SEC Filing  
6/24/2013Darren AlchVPSell1,500$51.59$77,385.00View SEC Filing  
6/21/2013Milton Mayo MorrisSVPSell4,569$51.47$235,166.43View SEC Filing  
6/17/2013Daniel Jeffrey MooreCEOSell7,000$51.61$361,270.00View SEC Filing  
6/17/2013Gregory H BrowneCFOSell16,426$51.69$849,059.94View SEC Filing  
6/12/2013Bryan D OlinVPSell7,000$52.30$366,100.00View SEC Filing  
6/7/2013David S WiseSVPSell5,000$52.21$261,050.00View SEC Filing  
6/7/2013Guy C JacksonDirectorSell7,500$51.75$388,125.00View SEC Filing  
6/7/2013Sherrie L PerkinsVPSell1,085$53.00$57,505.00View SEC Filing  
6/5/2013Daniel Jeffrey MooreCEOSell3,000$49.86$149,580.00View SEC Filing  
6/3/2013David S WiseSVPSell2,000$47.44$94,880.00View SEC Filing  
5/20/2013Milton Mayo MorrisSVPSell5,000$49.19$245,950.00View SEC Filing  
5/15/2013Daniel Jeffrey MooreCEOSell7,000$48.16$337,120.00View SEC Filing  
3/5/2013Daniel Jeffrey MooreCEOSell3,000$47.85$143,550.00View SEC Filing  
12/21/2012Alfred J NovakDirectorSell4,000$52.51$210,040.00View SEC Filing  
12/3/2012David S WiseSVPSell2,000$51.76$103,520.00View SEC Filing  
10/5/2012Daniel Jeffrey MooreCEOSell3,000$53.06$159,180.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cyberonics (NASDAQ CYBX) News Headlines

Source:
DateHeadline
Analyzing Glaukos (GKOS) & Cyberonics (CYBX)Analyzing Glaukos (GKOS) & Cyberonics (CYBX)
www.americanbankingnews.com - November 28 at 5:16 AM
Cyberonics (CYBX) & Stryker Corporation (SYK) Financial ReviewCyberonics (CYBX) & Stryker Corporation (SYK) Financial Review
www.americanbankingnews.com - October 9 at 8:10 AM
Comparing Second Sight Medical Products (EYES) and Cyberonics (CYBX)Comparing Second Sight Medical Products (EYES) and Cyberonics (CYBX)
www.americanbankingnews.com - August 20 at 2:28 PM
Contrasting Cerus Corporation (CERS) and Cyberonics (NASDAQ:CYBX)Contrasting Cerus Corporation (CERS) and Cyberonics (NASDAQ:CYBX)
www.americanbankingnews.com - August 6 at 7:12 AM
Contrasting ConforMIS (CFMS) and Cyberonics (NASDAQ:CYBX)Contrasting ConforMIS (CFMS) and Cyberonics (NASDAQ:CYBX)
www.americanbankingnews.com - July 26 at 11:58 PM
Health companies label thousands of patient deaths as injuriesHealth companies label thousands of patient deaths as 'injuries'
www.cnbc.com - August 19 at 3:38 PM
CYBERONICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or FailureCYBERONICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure
biz.yahoo.com - October 19 at 12:31 PM
CYBERONICS INC Files SEC form 8-K, Change in Directors or Principal OfficersCYBERONICS INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - October 16 at 5:28 PM

SEC Filings

Cyberonics (NASDAQ:CYBX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cyberonics (NASDAQ:CYBX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cyberonics (NASDAQ CYBX) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.